Work

P3.12.43 A Phase II Study of Sunvozertinib Combined With Anlotinib in NSCLC Patients Harboring EGFR Ex20Ins and Uncommon EGFR Mutations

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.905

Authors: H-Y. Xu, Y. Wang, R. Sun, H. Shi, L. Tian, F. Wei, Y. Wang

Institution: Chinese Academy of Medical Sciences & Peking Union Medical College

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519770

FWCI:

Cites:

Cited by:

Related to: